Literature DB >> 2539717

Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5.

A Koufos1, P Grundy, K Morgan, K A Aleck, T Hadro, B C Lampkin, A Kalbakji, W K Cavenee.   

Abstract

Wilms tumor of the kidney occurs with increased frequency in association with two clinically and cytogenetically distinct congenital syndromes, the Wiedemann-Beckwith syndrome (WBS) and the triad of aniridia, genitourinary anomalies, and mental retardation (WAGR). Constitutional deletions in the latter situation and similar alterations in sporadic Wilms tumors have implicated the chromosomal 11p13 region in neoplastic development. In contrast, some sporadic cases of WBS have been reported to have a constitutional duplication of chromosome 11p15. In order to resolve this seeming paradox, we have analyzed a family segregating WBS for linkage to DNA markers mapped to chromosome 11p. Consonant with the cytogenetic alterations in sporadic WBS cases, we obtained evidence for tight linkage of the mutation causing the syndrome to markers located at 11p15.5. Also consistent with this localization, we identified a subset of Wilms tumors, not associated with WBS, which have attained somatic homozygosity through mitotic recombination, with the smallest shared region of overlap being distal to the beta-globin complex at 11p15.5. These data provide evidence that familial WBS likely results from a defect at the same genetic locus as does its sporadic counterpart. Further, the data suggest there is another locus, distinct from that involved in the WAGR syndrome, which plays a role in the association of Wilms tumor with WBS.

Entities:  

Mesh:

Year:  1989        PMID: 2539717      PMCID: PMC1715635     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  44 in total

1.  Exomphalos-macroglossia-gigantism syndrome in Jamaican infants.

Authors:  M J Thorburn; E S Wright; C G Miller; E H Smith-Read
Journal:  Am J Dis Child       Date:  1970-04

2.  Polymorphic DNA region adjacent to the 5' end of the human insulin gene.

Authors:  G I Bell; J H Karam; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

3.  Nonrandom association of polymorphic restriction sites in the beta-globin gene cluster.

Authors:  S E Antonarakis; C D Boehm; P J Giardina; H H Kazazian
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

4.  Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells.

Authors:  M Goldfarb; K Shimizu; M Perucho; M Wigler
Journal:  Nature       Date:  1982-04-01       Impact factor: 49.962

5.  Somatic deletion and duplication of genes on chromosome 11 in Wilms' tumours.

Authors:  E R Fearon; B Vogelstein; A P Feinberg
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

6.  Loss of alleles at loci on human chromosome 11 during genesis of Wilms' tumour.

Authors:  A Koufos; M F Hansen; B C Lampkin; M L Workman; N G Copeland; N A Jenkins; W K Cavenee
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

7.  Loss of a Harvey ras allele in sporadic Wilms' tumour.

Authors:  A E Reeve; P J Housiaux; R J Gardner; W E Chewings; R M Grindley; L J Millow
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

8.  Development of homozygosity for chromosome 11p markers in Wilms' tumour.

Authors:  S H Orkin; D S Goldman; S E Sallan
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

9.  Abnormality of chromosome 11 in patients with features of Beckwith-Wiedemann syndrome.

Authors:  M Waziri; S R Patil; J W Hanson; J A Bartley
Journal:  J Pediatr       Date:  1983-06       Impact factor: 4.406

10.  Restriction sites containing CpG show a higher frequency of polymorphism in human DNA.

Authors:  D Barker; M Schafer; R White
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

View more
  84 in total

1.  Cloning, expression and localization of human BM88 shows that it maps to chromosome 11p15.5, a region implicated in Beckwith-Wiedemann syndrome and tumorigenesis.

Authors:  M Gaitanou; P Buanne; C Pappa; N Georgopoulou; A Mamalaki; F Tirone; R Matsas
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

2.  Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting.

Authors:  M P Lee; M R DeBaun; K Mitsuya; H L Galonek; S Brandenburg; M Oshimura; A P Feinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  The aetiology of cancer in the very young.

Authors:  J D Buckley
Journal:  Br J Cancer Suppl       Date:  1992-08

4.  The molecular basis of nephrogenesis and congenital kidney disease.

Authors:  J Bard
Journal:  Arch Dis Child       Date:  1992-08       Impact factor: 3.791

5.  Molecular analysis of patients with Wiedemann-Beckwith syndrome. II. Paternally derived disomies of chromosome 11.

Authors:  A Nyström; J E Cheetham; W Engström; P N Schofield
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

6.  Genetic mapping of the human tryptophan hydroxylase gene on chromosome 11, using an intronic conformational polymorphism.

Authors:  D A Nielsen; M Dean; D Goldman
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

7.  Nephrogenic rests mimicking Wilms' tumor on CT.

Authors:  Naveen Subhas; Pedram Argani; John P Gearhart; Stanley S Siegelman
Journal:  Pediatr Radiol       Date:  2003-10-07

8.  The importance of differentiating Simpson-Golabi-Behmel and Beckwith-Wiedemann syndromes.

Authors:  R Hughes-Benzie; J Allanson; A Hunter; T Cole
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

Review 9.  Candidate genes and potential targets for therapeutics in Wilms' tumour.

Authors:  Christopher Blackmore; Max J Coppes; Aru Narendran
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

Review 10.  Pediatric oncology.

Authors:  Andrew M Davidoff
Journal:  Semin Pediatr Surg       Date:  2010-08       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.